Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin E Baschal

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Diabetes Care|April 2, 2026
Differences in Clinical Manifestations and Islet Autoantibodies by Age in Adult-Onset Type 1 DiabetesKagan E Karakus, Maia G Clayton, Erin E Baschal, et al.
Diabetologia|January 14, 2026
Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomesKagan E Karakus, Lexie Chesshir, Sonya Walker, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetesTaylor M Triolo, Erin E Baschal, Taylor K Armstrong, et al.
Diabetes|December 11, 2007
Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complexTheresa A Aly, Erin E Baschal, Mohamed M Jahromi, et al.
JCI Insight|August 23, 2022
Temporal development of T cell receptor repertoires during childhood in health and diseaseAngela M Mitchell, Erin E Baschal, Kristen A McDaniel, et al.
Genes|July 2, 2021
Whole Exome Sequencing of 23 Multigeneration Idiopathic Scoliosis Families Reveals Enrichments in Cytoskeletal Variants, Suggests Highly Polygenic DiseaseElizabeth A Terhune, Cambria I Wethey, Melissa T Cuevas, et al.
Diabetes|May 22, 2007
HLA-DPB1*0402 protects against type 1A diabetes autoimmunity in the highest risk DR3-DQB1*0201/DR4-DQB1*0302 DAISY populationErin E Baschal, Theresa A Aly, Sunanda R Babu, et al.
The Journal of Clinical Endocrinology and Metabolism|July 16, 2010
Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's diseasePeter R Baker, Erin E Baschal, Pam R Fain, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 2011
Dominant suppression of Addison's disease associated with HLA-B15Peter R Baker, Erin E Baschal, Pam R Fain, et al.
Journal of Diabetes|June 3, 2011
Replication and further characterization of a Type 1 diabetes-associated locus at the telomeric end of the major histocompatibility complexErin E Baschal, Suparna A Sarkar, Theresa A Boyle, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Diabetes Care|April 2, 2026
Differences in Clinical Manifestations and Islet Autoantibodies by Age in Adult-Onset Type 1 DiabetesKagan E Karakus, Maia G Clayton, Erin E Baschal, et al.
Diabetologia|January 14, 2026
Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomesKagan E Karakus, Lexie Chesshir, Sonya Walker, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetesTaylor M Triolo, Erin E Baschal, Taylor K Armstrong, et al.
Diabetes|December 11, 2007
Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complexTheresa A Aly, Erin E Baschal, Mohamed M Jahromi, et al.
JCI Insight|August 23, 2022
Temporal development of T cell receptor repertoires during childhood in health and diseaseAngela M Mitchell, Erin E Baschal, Kristen A McDaniel, et al.
Genes|July 2, 2021
Whole Exome Sequencing of 23 Multigeneration Idiopathic Scoliosis Families Reveals Enrichments in Cytoskeletal Variants, Suggests Highly Polygenic DiseaseElizabeth A Terhune, Cambria I Wethey, Melissa T Cuevas, et al.
Diabetes|May 22, 2007
HLA-DPB1*0402 protects against type 1A diabetes autoimmunity in the highest risk DR3-DQB1*0201/DR4-DQB1*0302 DAISY populationErin E Baschal, Theresa A Aly, Sunanda R Babu, et al.
The Journal of Clinical Endocrinology and Metabolism|July 16, 2010
Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's diseasePeter R Baker, Erin E Baschal, Pam R Fain, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 2011
Dominant suppression of Addison's disease associated with HLA-B15Peter R Baker, Erin E Baschal, Pam R Fain, et al.
Journal of Diabetes|June 3, 2011
Replication and further characterization of a Type 1 diabetes-associated locus at the telomeric end of the major histocompatibility complexErin E Baschal, Suparna A Sarkar, Theresa A Boyle, et al.
Pageof 3